Extracellular Gal-1 has been found altered in many cancer cell types (Thijssen et al. 2015), including melanoma (Yazawa et al. 2015), ovarian (Zhang et al. 2014) and prostate cancers (Laderach et al. 2013). This evidence concerns the gene LGALS1 and prostate carcinoma.